“Ruchit Jain recommends buying Granules India in the near-term at a CMP of ₹740, with a target of ₹840 and a stop loss at ₹690. The call is based on the Nifty Pharma Index breaking an 18-month consolidation, suggesting a sector rally, and Granules India's recent outperformance, surpassing previous highs with increasing volumes and positive RSI momentum.”